D-1844-2019 Class II Terminated
FDA drug recall D-1844-2019 was initiated by Macleods Pharma Usa Inc on Jul 17, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Feb 9, 2021). Affected quantity: a) 5448 bottles b) 972 bottles c) 158 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 21, 2019
- Initiation Date
- Jul 17, 2019
- Termination Date
- Feb 9, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 5448 bottles b) 972 bottles c) 158 bottles
Product description
Tamsulosin Hydrochloride Capsules, USP 0.4 mg Rx only a) 100 count (NDC 33342-159-11), b) 500 count (NDC 33342-159-15) and c) 1000 count (NDC 33342-159-44) bottles, Manufactured : Macleods Pharma USA, Inc Plainsboro, NJ Manufactured by: Macleods Pharmaceuticals Ltd Baddi, Himchal Pradesh, INDIA
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide
Code information
a) BTP803A, exp 08/2020; b) BTP802A, exp 07/2020, BTP901A, exp 12/2020; c) BTP802B, exp 07/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1844-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026